Galectin-3
Galectin-3 is filed under cardiac markers, yet it is really a scarring protein found across the body. A high level does not point at the heart by itself, and it has to be read against kidney function.
Part of the Cardiac Markers — see all 10 values together, including B-Type Natriuretic Peptide, Creatine Kinase-MB, Lipoprotein-Associated Phospholipase A2.
A result filed under cardiac markers reads like a verdict on the heart. Galectin-3 wears that label, and the heading promises more focus than the molecule actually keeps. The same number climbs with kidney scarring, liver scarring, and lung scarring, and it rises as kidney function falls, so a high galectin-3 does not name the heart by itself. The report's category is tidier than the biology behind it.
Galectin-3 is best understood as a repair crew that scars whatever it touches. It is a protein the body deploys when tissue is injured, helping fibroblasts move in and lay down collagen to wall off the damage. The Int J Mol Sci review describes it as a marker of fibrosis found across many tissues, with a role in cardiac, pulmonary, liver, and kidney disease. The crew that patches a wound is the same crew that, when it never stands down, stiffens an organ with scar. In the heart that stiffening shows up as remodeling. The trouble is that the crew works everywhere, so the blood level reports total scarring activity without telling you which job site is busy.
That is the gap between what the test is sold as and what it measures. Lab marketplaces file galectin-3 squarely as a heart number and recite a set of risk cutoffs. Both things can be true at once: it carries real prognostic weight in heart failure, and it is a cross-organ fibrosis protein whose elevation can be coming from the kidney instead. Reading it well means holding both facts together.
What the numbers usually mean
The figures that circulate for galectin-3 are risk thresholds from the assay's labeling, not a clean healthy-versus-sick line. They sort people into broad risk tiers, and an independent healthy-donor study found a meaningfully different picture once age was accounted for, so every number here travels with a caveat.
How a galectin-3 result is usually read
ng/mLThe low band on the FDA-cleared assay's risk labeling. A value here is the reassuring end, though galectin-3 was cleared for additive risk stratification to be read alongside clinical evaluation, not as a standalone all-clear.
The middle risk band on the assay labeling. Worth noting against the independent healthy-donor study, where the 97.5th-percentile upper limit came out near 26.1 ng/mL, so a number in this stretch can still fall inside a healthy reference depending on the population and method.
The high band on the assay labeling. It raises the prognostic flag but does not name the organ, and it has to be weighed against kidney function before it means much.
In healthy donors the upper limit was 31.5 ng/mL over age 45 versus 21.8 ng/mL at 45 or younger, and an optimal cutoff of 31.5 ng/mL has been reported for patients with renal dysfunction. The line that matters moves with who you are and how your kidneys are working.
These bands explain why "is 20 normal" has no single answer. A galectin-3 of 20 sits in the intermediate risk tier on the assay labeling, yet falls under the 21.8 ng/mL healthy upper limit for someone 45 or younger, and well under the 31.5 ng/mL limit for an older person. The same dot reads three ways depending on the reference you hold it against.
What a high galectin-3 means
A high galectin-3 means the scarring crew is busy. It does not, on its own, say where. This is the part the heart-only framing hides, and it is the reason the result so often confuses people who feel fine.
What can push galectin-3 high
-
Reduced kidney function
The most underplayed driver. Levels correlate negatively with eGFR, so as filtration falls the number rises, and higher galectin-3 has been shown to precede and predict new chronic kidney disease and faster eGFR decline. This is why the result is read beside kidney numbers, not in isolation.
-
Cardiac remodeling and heart failure
The use the test was cleared for. Galectin-3 drives fibroblast growth and collagen deposition as the heart stiffens, and it tracks with natriuretic peptides like NT-proBNP rather than with pump function on the echo.
-
Fibrosis in other organs
Liver and lung disease involve the same scarring biology, so an elevation can be reporting fibrosis well away from the heart.
-
Older age
The healthy upper limit is substantially higher over 45, so part of a high reading can simply be the reference range moving with age.
-
Some advanced cancers and inflammatory states
Galectin-3 can also rise in certain advanced cancers and other fibrosis- and inflammation-associated conditions, which further limits how heart-specific the number is.
There is one feature that makes galectin-3 behave unlike the acute cardiac markers. It barely moves. In a heart-failure study, cardiac resynchronization therapy did not significantly change the concentration across 18 months, which fits a protein reporting a slow remodeling process rather than today's decompensation. That steadiness is also why galectin-3 reflects fibrotic and renal status but does not track the echocardiographic measures of pump function. It is a marker of the scar, not of the strain in the moment.
How a doctor reads it from here
Because the number names a process and not an organ, the next steps are about narrowing down where the scarring is and how much it matters for you. That work belongs with a clinician, not a search bar.
Turning a high galectin-3 into a plan
-
1
Bring the result to your doctor with the full panel
Galectin-3 was cleared for additive risk stratification to be interpreted alongside clinical evaluation. It is one input among several, so it is read with the rest of your cardiac and kidney results, not alone.
-
2
Have it read against your kidney function
Because levels climb as eGFR falls, clinicians account for renal function when interpreting the value. In one cohort the prognostic signal held only in patients with renal dysfunction, so the kidney context can change what the number means.
-
3
Ask which question it is answering
Galectin-3 is a prognosis and remodeling marker, not a diagnostic one, and it is weaker than NT-proBNP for sorting acute heart failure. Knowing it speaks to long-term risk rather than today's diagnosis sets the right expectation.
-
4
Watch the direction over repeated tests
A slow-moving marker is defined by its trajectory more than any single draw, and since the circulating risk cutoffs come from one assay's labeling, what a reference cutoff actually represents matters more here than any one snapshot.
No consumer routine has been shown to lower galectin-3, and chasing the value itself misses the point. The productive target is whatever is driving the fibrosis, which is a conversation a doctor leads.
Reading galectin-3 in context
Galectin-3 sits on the cardiac markers panel, where it plays a different role than its neighbors. The natriuretic peptides there, BNP and its sibling fragment, report the pressure and stretch of a straining heart; the way those two peptides differ is worth knowing, but both are stress signals. Troponin reports outright heart-muscle injury. Galectin-3 reports the slow scarring underneath, and hs-CRP reports the smouldering inflammation that often feeds it. Among the newer entries, the vascular-inflammation enzyme Lp-PLA2 is another marker that earns its place by adding information the older numbers miss rather than restating them.
If your galectin-3 came back high, the guide to reading cardiac markers walks through how these numbers are weighed together instead of one at a time. And because galectin-3 is, by its biology, a marker that changes slowly, its meaning lives in the line over time far more than in any single value.
Sources
- The Role of Galectin-3 in Heart Failure (Int J Mol Sci review, PMC)
- Establishing the upper reference limit of Galectin-3 in healthy blood donors (PMC)
- Galectin-3 and New-Onset CKD: Marker or Mediator? (PMC)
- Galectin-3: association to renal function, neurohumoral activity and echocardiographic parameters in outpatients with heart failure (PMC)
- American Heart Association — Heart Failure (patient overview)
Written and reviewed by BloodSight Editorial Team · Last updated
See your Galectin-3 on one timeline.
BloodSight calibrates the reference range to your sex, age, and lab — and shows every value across every visit.
In your personal range
Normal ranges
| Group | Range | Unit |
|---|---|---|
| Adult Male | 0–17.8 | ng/mL |
| Adult Female | 0–17.8 | ng/mL |
Reference ranges may vary by laboratory and individual factors.
Galectin-3 — Common Questions
Is galectin-3 only a heart test, or can other organs raise it?
Does kidney function change how my galectin-3 result should be read?
How is galectin-3 different from BNP or NT-proBNP?
Can I lower my galectin-3 level, or does treatment not change it?
Why is my galectin-3 higher just because I'm older?
Does a normal galectin-3 rule out heart failure?
Disclaimer
This content is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Reference ranges may vary by laboratory. Always discuss your results with a qualified healthcare professional.
Related Tests
NT-proBNP is the signal a stretched heart wall sends out under strain. Its most decisive answer is often the quiet one: a low number that takes heart failure off the table.
A heart-failure number that can climb precisely because the newest drug is doing its job, and read low when extra weight quietly clears it away.
hs-CRP and standard CRP measure the same liver-made protein. The difference is which question each version can hear: the high-sensitivity assay resolves the low range where heart risk hides.
Lp-PLA2 is sold as a clean signal of dangerous plaque. But most of the enzyme rides bound to LDL, so a high count can mean the cholesterol convoy is large rather than that the artery wall is breaking apart.
Troponin is the protein heart-muscle cells leak when they are injured. With modern high-sensitivity tests the diagnosis no longer rides on a single number, but on whether that number is rising between draws.